- 2012
- Press releases - 25.01.2012
Identification of a recurrent chromosomal anomaly in neural cells derived from pluripotent stem cells (ES and iPS)
At a time when the first regenerative medicine clinical trials are being performed using pluripotent stem cells, teams from the I-Stem Institute, directed by Marc Peschanski
- Press releases - 23.01.2012
Obesity: Does our second brain work too well?
Scientists from Inserm have just demonstrated how a high fat and sugar diet prevents the natural destruction of neurons from the enteric nervous system in mice.
- Press releases - 20.01.2012
3 is the magic number: A chain reaction required to prevent tumor formation
The expression of p53 and Mdm2 is closely related. In an article published this week in the Cancel Cell review, Robin Fahraeus and his collaborators from Inserm Unit 940 (“Therapeutic Targets for Cancer”), demonstrate that cellular response to DNA damage requires involvement from the protein kinase ATM so that Mdm2 can positively or negatively control protein p53. […]
- Press releases - 19.01.2012
A new way to stimulate the immune system and fight infection
A study carried out by Eric Vivier and Sophie Ugolini at the Marseille-Luminy Centre for Immunology (Inserm/CNRS/Université Aix Marseille) has just reveal a gene in mice which, when mutated, can stimulate the immune system to help fight against tumours and viral infections. Whilst this gene was known to activate one of the body’s first lines […]
- Press releases - 18.01.2012
“Senior” runners never stop pushing their limits in marathons
Romauld Lepers and Thomas Cattagni, researchers from Inserm Unit 1093 “Cognition, Action and Sensorimotor Plasticity” at the Université de Bourgogone, have analysed changes in participation and performance of runners aged 20 to 80 in the New York marathon over the last 30 years. The results are largely unexpected: the best male marathon runners over 65 […]
- Press releases - 18.01.2012
Vitamin D receptor: first full 3D observation
For the first time, a team from the Institute of Genetics and Molecular and Cellular Biology (IGBMC, Université de Strasbourg/CNRS/Inserm) has succeeded in taking a full, 3D photograph in HD (1) of a small vital,
- Press releases - 05.01.2012
The onset of cognitive decline begins at 45
Abundant evidence has clearly established an inverse association between age and cognitive performance, but the age at which cognitive decline begins is much debated.
- Press releases - 03.01.2012
Our endocrine system has a good memory!
On hearing the word ‘memory’, the brain normally springs to mind… or perhaps our immune system, which memorizes data to react more effectively should bacteria infect us a second time.
- 2011
- Press releases - 02.11.2011
Erasing the signs of aging in cells is now a reality
Inserm’s AVENIR “Genomic plasticity and aging” team, directed by Jean-Marc Lemaitre, Inserm researcher at the Functional Genomics Institute (Inserm/CNRS/Université de Montpellier 1 and 2), has recently succeeded in rejuvenating cells from elderly donors (aged over 100).
- Press releases - 24.03.2011
(French) Un diurétique pour mieux soigner les épilepsies infantiles
En étudiant chez l’animal l’action de deux antiépileptiques, l’équipe de Yehezkel Ben-Ari de l’unité Inserm 901 “INMED – Institut de neurobiologie de la méditerranée” vient de montrer comment les crises infantiles peuvent s’aggraver au fur et à mesure des répétitions et entraîner une perte d’efficacité des traitements classiques, notamment lorsqu’ils sont pris tardivement.